Cargando…
Developing the latest framework to measure and incentivise pharmaceutical industry contributions to health research and development
Major pharmaceutical companies contribute important expertise to health research and development (R&D), particularly in their ability to develop and bring pharmaceuticals to market. The Access to Medicine Index evaluates how 20 of the world’s largest pharmaceutical companies are directing R&...
Autores principales: | Cole, Clarke B., Trolle, Stine, Edwards, Danny J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090890/ https://www.ncbi.nlm.nih.gov/pubmed/30071858 http://dx.doi.org/10.1186/s12961-018-0332-y |
Ejemplares similares
-
Challenges and opportunities for incentivising antibiotic research and development in Europe
por: Anderson, Michael, et al.
Publicado: (2023) -
Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?
por: Kobashi, Yurie, et al.
Publicado: (2019) -
Pharmaceutical Policy Part 2 Pharmaceutical engagement and policy development: a framework for influence
por: Morrow, Norman C
Publicado: (2015) -
Effect of financial incentives on incentivised and non-incentivised clinical activities: longitudinal analysis of data from the UK Quality and Outcomes Framework
por: Doran, Tim, et al.
Publicado: (2011) -
Effect of financial incentives on incentivised and non-incentivised clinical activities: longitudinal analysis of data from the UK Quality and Outcomes Framework
Publicado: (2013)